Mesenchymal stem cells as a valuable agent in osteoarthritis treatment

Osteoarthritis (OA), a common disease that originates from cartilage damage, affects approximately 250 million people around the world (1). The disease is more common in older people. Among younger and middle-aged people, injuries are the most common causative agents for OA (2).